What should patients pay attention to when using Quizartinib?

Quizatinib is a drug used to treat acute myeloid leukemia (AML) , but during use, patients need to pay special attention to a serious side effect that it may cause - QT interval prolongation. QT Prolonged QT interval is an irregular heartbeat that may lead to serious consequences such as syncope, loss of consciousness, seizures and even sudden death. For those who have or have had QT prolonged syndrome (a hereditary disease in which patients’ heart electrical activity is abnormal, they are more likely to develop QT< /span>interval prolongation), or patients with a history of low potassium, low magnesium, arrhythmia, and heart failure, be sure to inform your doctor in detail about your health status before using quizartinib, because these factors may increase the risk of serious cardiac events.

In addition, the concomitant use of quizartinib with certain drugs may further increase the risk of QT prolongation. Therefore, before starting treatment, patients must fully disclose all medications they are taking to their doctors and pharmacists so that professionals can evaluate potential drug interactions. During the treatment process, patients should remain highly vigilant. If symptoms such as abnormally rapid heartbeat, violent or irregular beating, fainting, loss of consciousness, or epileptic seizures occur, they should stop taking the medicine immediately and contact a doctor urgently.

To ensure safe treatment, it is important to follow your doctor's instructions. Patients are required to attend all medical appointments and undergo necessary laboratory tests to monitor the body's response to Quizartinib. At the same time, regular electrocardiogram (EKG) examination is also indispensable, which can help doctors promptly detect and deal with any abnormalities in cardiac electrical activity, ensuring that patients can use Quizartinib safely throughout the entire treatment process. Maintaining close communication with the doctor and jointly discussing the risks and benefits of treatment is the key to ensuring treatment effectiveness and reducing adverse reactions.

xa0

Reference: https://medlineplus.gov/druginfo/meds/a623034.html